# Progress Note 06 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sigmund Freud (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET005-SYN
- Date: 2026-09-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anton Reinholt, MD
- Calendar frame: modern shifted

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Subsequent annual wellness visit. **S**

## History of present illness

Mr. Freud is a 74-year-old physician and writer, seven years after a right partial maxillectomy for squamous cell carcinoma of the palate, with tobacco use disorder in early remission, who comes for his subsequent annual wellness visit five weeks after his twelve-week review and two weeks after the sick visit for Candida stomatitis. The burning has gone and the white patches have cleared; he now brushes the obturator and leaves it out at night. He has not smoked for ten weeks. He finished the 14 mg patch today as planned and keeps varenicline 1 mg twice daily and a few lozenges a day. His pain is 2 of 10 on acetaminophen. His weight is 60.2 kg. His remaining question is whether he should have a scan of his lungs. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 74 |
| Tobacco | No smoking for ten weeks; patch finished today; varenicline continues |
| Mouth | Candida stomatitis healed; no sore, lump or bleeding |
| Mood and cognition | PHQ-2 0; Mini-Cog 5 of 5 |
| Medicines | Varenicline 1 mg twice daily, nicotine 4 mg lozenge as needed, acetaminophen 1,000 mg three times daily |

## Health risk assessment

Completed by the patient on paper before the visit and reviewed with him by Dr. Reinholt. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good; better than in the spring |
| Psychosocial | Lives with his household; works most days; close colleagues; no loneliness |
| Behavioral | No tobacco for ten weeks; rarely a glass of wine; walks daily; soft high-protein diet; sleeps about seven hours |
| Activities of daily living | Independent in bathing, dressing, eating, toileting and transfers |
| Instrumental activities of daily living | Manages his own medicines, money, correspondence and appointments |
| Home safety | Smoke detectors working; handrail on the stairs; no falls in the past year |
| Hearing and vision | Hears well in conversation; reading glasses; eye examination this year |
| Bladder | Gets up once at night to pass urine; no leakage |
| Memory | No concerns |
| Oral health | New obturator; dental cleaning every three months |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up 1.8 kg since the spring; no fever or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Mouth no longer sore; no nasal leakage; speech clear with the obturator |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Respiratory | Positive | Less morning cough since he stopped smoking; no breathlessness or blood in sputum |
| Gastrointestinal | Negative | No trouble swallowing, abdominal pain or change in bowel habit |
| Genitourinary | Negative | No blood in the urine |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No new skin lesions |
| Neurological | Negative | No numbness of the face or weakness |
| Psychiatric | Negative | Mood steady; PHQ-2 0 |

11 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks **S**
- Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesis **S**
- Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 130/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 60.2 kg; BMI 20.3 kg/m². All vital signs are synthetic.

PHQ-2: 0; Mini-Cog: 5. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, high-dose, this season **S**
- Pneumococcal conjugate vaccine (PCV20), one dose **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 60.2 kg, BMI 20.3; blood pressure 130/78; pulse 70 |
| Mouth | With the obturator out: palate and defect margins pink and healed, no plaques, ulcer, mass or induration; obturator clean and well fitting |
| Neck | No lymph nodes felt |
| Cardiovascular | Regular rhythm; no murmur; no abdominal bruit |
| Respiratory | Clear to auscultation bilaterally |
| Musculoskeletal | Timed Up and Go 10 seconds |
| Neurological | Oriented; Mini-Cog 5 of 5 (recall 3 of 3, clock normal) |
| Psychiatric | Engaged and ironic; mood steady |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed and the written screening schedule updated. Lung cancer screening was discussed in detail: the USPSTF criteria count cigarette pack-years, and he smoked cigarettes only briefly, but about fifty years of heavy cigar smoking with some inhalation carries a real lung cancer risk, he has had a smoking-related cancer, and he is fit for treatment. He understood the possible benefit, false positives and radiation, and chose screening. One-time aortic aneurysm screening is recommended for men 65 to 75 who have smoked. **S**
   - Low-dose CT of the chest.
   - Ultrasound of the abdominal aorta.
   - Influenza and pneumococcal vaccines today.
2. **Candida stomatitis** (B37.0). Healed after nystatin and better prosthesis hygiene; no area of concern. **S**
   - Nystatin finished; continue nightly cleaning and leaving the obturator out at night.
3. **Tobacco use disorder, severe, in early remission** (F17.290). Ten weeks without smoking. **S**
   - Patch stopped today as planned; continue varenicline to complete at least 24 weeks and lozenges as needed.
4. **Raised LDL cholesterol with a high cardiovascular risk** (E78.5). Estimated 10-year cardiovascular risk over 20% after fifty years of smoking, with an LDL of 126 mg/dL; after discussion he chose a statin. **S**
   - Atorvastatin 20 mg daily; ALT and symptoms at the next visit.

## Medication changes

- Stopped: Nicotine 14 mg/24 hours transdermal patch, one patch each morning for four weeks, then stop **S**
- Stopped: Nystatin 100,000 units/mL oral suspension, 5 mL swished around the mouth and defect for as long as possible and then swallowed, four times daily with the obturator out, for 14 days **S**
- Started: Atorvastatin 20 mg oral tablet, one tablet daily **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Lung cancer screening | Ordered | Low-dose CT chosen by shared decision; the USPSTF criteria use cigarette pack-years, so cigar smoking needs an individual decision |
| Abdominal aortic aneurysm screening | Ordered | One-time ultrasound for men 65 to 75 who have ever smoked |
| Colorectal cancer screening | Up to date | Normal colonoscopy six years ago; screening after 75 to be decided individually |
| Head and neck cancer surveillance | Up to date | Yearly examination by his head and neck surgeon, last done in the summer with no recurrence |
| Tobacco cessation | Completed today | Ten weeks abstinent on varenicline; relapse plan reviewed |
| Statin for primary prevention | Completed today | Atorvastatin 20 mg started by shared decision |
| Depression screening | Completed today | PHQ-2 score 0 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls prevention | Completed today | No falls; Timed Up and Go 10 seconds; walks daily |
| Alcohol misuse screening | Completed today | Rarely a glass of wine; no misuse |
| Blood pressure | Completed today | 130/78 mmHg |
| Diabetes screening | Up to date | HbA1c 5.5% in the spring |
| Influenza vaccine, this season | Completed today | High-dose vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; no further doses needed |
| COVID-19 vaccine, this season | Due | Recommended; he will have it at his pharmacy next month |
| Recombinant zoster vaccine | Up to date | Two-dose series completed three years ago |
| RSV vaccine | Not indicated | Recommended at 75, or at 50 to 74 with a condition that raises the risk; to be offered at 75 |
| Tetanus booster | Up to date | Tdap four years ago |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think, read and work, and that he would not want treatment that only prolongs suffering when work and thought are no longer possible. He asked for good pain relief if his cancer ever returns. No specific treatment orders were recorded today. The plan will be revisited yearly or after any serious illness. **S**

## Guideline basis

- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020), American Thoracic Society (Am J Respir Crit Care Med 2020;202(2):e5-e31)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Lung Cancer: Screening (2021), U.S. Preventive Services Task Force
- Abdominal Aortic Aneurysm: Screening (2019), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Low-dose CT and aortic ultrasound in two weeks. Five-month review in four weeks with blood count, albumin, kidney function and ALT. Next wellness visit in one year. **S**
- Next scheduled visit 2026-10-26: five-month review: abstinence, lung and aortic screening results, pain, weight and the survivorship plan. **S**
